ClinicalTrials.Veeva

Menu

The Effect of Inhalation Agent on the QTc Interval During Liver Transplantation: Sub Study (NCT01886664)

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Anesthesia, General

Treatments

Drug: Desflurane
Drug: Sevoflurane

Study type

Observational

Funder types

Other

Identifiers

NCT01899248
YSJeon_liver transplantation

Details and patient eligibility

About

The purpose of this study is to assess the effects of inhalation agent on corrected QT interval duration during liver transplantation.

Enrollment

52 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • elective liver transplantation

Exclusion criteria

  • age < 18, age > 65
  • patient refusal
  • re-transplantation

Trial design

52 participants in 2 patient groups

Sevoflurane
Description:
Performing liver transplantation under general anesthesia using sevoflurane
Treatment:
Drug: Sevoflurane
Desflurane
Description:
Performing liver transplantation under general anesthesia using desflurane
Treatment:
Drug: Desflurane

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems